Hepatitis
Hepatitis(肝炎)
Hepatitis 相关产品(53)
- GC46805Adefovir-d4CAS: 1190021-70-5纯度: >99.00%
An internal standard for the quantification of adefovir
- GC46936Boceprevir-d9CAS: 1256751-11-7纯度: >99.00%
An internal standard for the quantification of boceprevir
- GC47551Ledipasvir-d6CAS: 2050041-12-6纯度: >99.00%
An internal standard for the quantification of ledipasvir
- GC48006PSI-7977-13C-d3CAS: 2070009-25-3纯度: >99.00%
An internal standard for the quantification of PSI-7977
- GC48130Taurohyocholic Acid (sodium salt)CAS: 117997-17-8纯度: >95.00%
A taurine-conjugated form of hyocholic acid
- GC48143Tenofovir-d6CAS: 1020719-94-1纯度: >99.00%
An internal standard for the quantification of tenofovir
- GC48220Umifenovir-d6 (hydrochloride)CAS: 2928218-29-3纯度: >99.00%
A neuropeptide with diverse biological activities
- GC49010Taurohyocholic Acid-d4 (sodium salt)纯度: >99.00%
An internal standard for the quantification of taurohyocholic acid
- GC49165GS-441524 tris-isobutyryl esterCAS: 2563617-99-0纯度: >98.00%
An orally bioavailable prodrug form of GS-443902
- GC492941-(4-Chlorobenzhydryl)piperazineCAS: 303-26-4纯度: >98.00%
An inactive metabolite of meclizine and chlorcyclizine
- GC49357N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 2-ethylbutyl esterCAS: 1354823-36-1纯度: >98.00%
A synthetic intermediate
- GC49395Ribavirin-13C5CAS: 1646818-35-0纯度: >95.00%
An internal standard for the quantification of ribavirin
- GC498232′-C-β-MethylguanosineCAS: 374750-30-8纯度: >95.00%
An active nucleoside metabolite of BMS-986094
- GC52261Entecavir-d2CAS: 142217-69-4纯度: >99.00%
An internal standard for the quantification of entecavir
- GC524462-Nonylquinolin-4(1H)-one-d4纯度: >99.00%
An internal standard for the quantification of 2-nonylquinolin-4(1H)-one
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC46805 | Adefovir-d4 | 1190021-70-5 | >99.00% | |
An internal standard for the quantification of adefovir | ||||
| GC46936 | Boceprevir-d9 | 1256751-11-7 | >99.00% | |
An internal standard for the quantification of boceprevir | ||||
| GC47266 | D-Ornithine lactam | 88763-76-2 | >95.00% | |
A building block | ||||
| GC47330 | Faldaprevir-d6 | 2750534-88-2 | >99.00% | |
Faldaprevir-d6 是氘标记的 Faldaprevir。 | ||||
| GC47551 | Ledipasvir-d6 | 2050041-12-6 | >99.00% | |
An internal standard for the quantification of ledipasvir | ||||
| GC48006 | PSI-7977-13C-d3 | 2070009-25-3 | >99.00% | |
An internal standard for the quantification of PSI-7977 | ||||
| GC48036 | Remdesivir-d4 | 2738376-82-2 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48130 | Taurohyocholic Acid (sodium salt) | 117997-17-8 | >95.00% | |
A taurine-conjugated form of hyocholic acid | ||||
| GC48136 | Telaprevir-d4 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48143 | Tenofovir-d6 | 1020719-94-1 | >99.00% | |
An internal standard for the quantification of tenofovir | ||||
| GC48220 | Umifenovir-d6 (hydrochloride) | 2928218-29-3 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48464 | GC376 (sodium salt) | 1416992-39-6 | >98.00% | |
An inhibitor of 3C- and 3C-like proteases | ||||
| GC49010 | Taurohyocholic Acid-d4 (sodium salt) | - | >99.00% | |
An internal standard for the quantification of taurohyocholic acid | ||||
| GC49165 | GS-441524 tris-isobutyryl ester | 2563617-99-0 | >98.00% | |
An orally bioavailable prodrug form of GS-443902 | ||||
| GC49177 | Loliolide | 5989-02-6 | >98.00% | |
Loliolide是一种具有多种生物活性的单萜内酯。 | ||||
| GC49284 | GSK-A1 | 1416334-69-4 | >98.00% | |
A PI4KIIIα inhibitor | ||||
| GC49294 | 1-(4-Chlorobenzhydryl)piperazine | 303-26-4 | >98.00% | |
An inactive metabolite of meclizine and chlorcyclizine | ||||
| GC49357 | N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 2-ethylbutyl ester | 1354823-36-1 | >98.00% | |
A synthetic intermediate | ||||
| GC49395 | Ribavirin-13C5 | 1646818-35-0 | >95.00% | |
An internal standard for the quantification of ribavirin | ||||
| GC49823 | 2′-C-β-Methylguanosine | 374750-30-8 | >95.00% | |
An active nucleoside metabolite of BMS-986094 | ||||
| GC52261 | Entecavir-d2 | 142217-69-4 | >99.00% | |
An internal standard for the quantification of entecavir | ||||
| GC52446 | 2-Nonylquinolin-4(1H)-one-d4 | - | >99.00% | |
An internal standard for the quantification of 2-nonylquinolin-4(1H)-one | ||||
| GC61002 | Lomibuvir | 1026785-55-6 | >99.50% | |
An HCV polymerase inhibitor | ||||
| GC61071 | MK-0608 | 443642-29-3 | >99.00% | |
MK-0608是一种有效的HCV复制抑制剂，在亚基因组复制子测定中，EC50为0.3μM(EC90=1.3μM)。 | ||||